Fair 48°
Tag:

Drug Recall

Business
Pfizer Pills Recalled Due To Increased Cancer Risk Pfizer Pills Recalled Due To Increased Cancer Risk
Pfizer Pills Recalled Due To Increased Cancer Risk Pfizer has issued a recall for blood pressure pills that were distributed across the United States due to the presence of an organic compound it said could increase the risk of cancer. The five lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient level due to the presence of a nitrosamine, Nnitroso-quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level, the Food and Drug Administration announced. "These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time," the FDA sai…

SHARE

by Joe Lombardi
News
FDA Recalls Drug From Long Island Supplier That May Contain High Levels Of Cancer-Causing Agent FDA Recalls Drug From Long Island Supplier That May Contain High Levels Of Cancer-Causing Agent
FDA Recalls Drug From Long Island Supplier That May Contain High Levels Of Cancer-Causing Agent The FDA has expanded a recall of a highly prescribed diabetes drug that may contain high levels of a cancer-causing agent. Metformin hydrochloride extended-release tablets, 500mg, & 750mg, was originally recalled in June, after it was found to contain higher-than-normal levels of a known carcinogen, the FDA said. In the new recall, an additional 76 lots of the drugs have been recalled. The original metformin drug that is not time-released is not included in the recall. The original recall was initiated after it was found the drug contained unsafe levels of nitrosodimethylamine, which …

SHARE

by Kathy Reakes
News
Cancer Fears Prompt Walgreens, Rite Aid, CVS To Suspend Sale Of Zantac Cancer Fears Prompt Walgreens, Rite Aid, CVS To Suspend Sale Of Zantac
Cancer Fears Prompt Walgreens, Rite Aid, CVS To Suspend Sale Of Zantac Walgreens, Rite Aid and CVS are all temporarily taking heartburn medicine Zantac off their shelves due to the potential presence of a human carcinogen. The move comes after a product alert was issued by the U.S. Food and Drug Administration warning that the products contain low levels of nitrosodimethylamine (NDMA). Zantac has not currently been recalled, but the FDA is researching to determine if the low levels of NDMA pose a risk. The initial report found that the amounts “barely exceed amounts found in common foods.” CVS was first to pull the product, announcing the move Saturday, Sept…

SHARE

by Zak Failla